Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research on Efficacy of Teriparatide use in the Return of recruits to Normal duty

Trial Profile

Research on Efficacy of Teriparatide use in the Return of recruits to Normal duty

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Fracture; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms RETURN
  • Most Recent Events

    • 21 Sep 2021 protocol of study is amended for calcium and vitD supplement if serum calcium is less than 2mmo/l ;requirement for participants to be prescribed vitamin D as part of standard care(if vitamin D deficient); MRI scans at weeks 20 and 24, if a fracture remains unhealed at week 16; a subgroup of participants to wear accelerometers to assess physical activity levels; clarification regarding randomisation where allocation will stratified by vit D status and single or multiple lower body stress fracture
    • 30 Aug 2021 Trial design, published in the Trials
    • 03 Nov 2020 Planned End Date changed from 2 Apr 2021 to 1 Oct 2022.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top